Previous studies have shown that EZH2 silencing reduced cancer cell growth, migration and invasion in SCCHN (Liu et al., 2013; Chang et al., 2016), but which lack transgenic animal experiments and does not involve the influence of EZH2 on tumor microenvironment regulation of tumor genesis and development. This evidence concerns the gene EZH2 and cancer.